SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 390 filers reported holding SEATTLE GENETICS INC in Q1 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $324,000 | +29.6% | 2,843 | -3.1% | 0.14% | +23.3% |
| Q3 2019 | $250,000 | -35.1% | 2,935 | -47.3% | 0.12% | -32.2% |
| Q2 2019 | $385,000 | +58.4% | 5,565 | +67.6% | 0.17% | +64.4% |
| Q1 2019 | $243,000 | -45.5% | 3,320 | -57.9% | 0.10% | -53.2% |
| Q4 2018 | $446,000 | -13.6% | 7,880 | +17.9% | 0.22% | -2.2% |
| Q3 2018 | $516,000 | -2.6% | 6,685 | -16.2% | 0.23% | -9.2% |
| Q2 2018 | $530,000 | +6.0% | 7,980 | -16.5% | 0.25% | -5.3% |
| Q1 2018 | $500,000 | – | 9,555 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 44,100,294 | $2,381,857,000 | 21.61% |
| Lagoda Investment Management, L.P. | 567,057 | $30,627,000 | 9.21% |
| Redmile Group, LLC | 1,781,470 | $96,217,000 | 7.65% |
| Boxer Capital, LLC | 232,600 | $12,563,000 | 5.63% |
| NEXTHERA CAPITAL LP | 111,500 | $6,022,000 | 3.70% |
| Eventide Asset Management | 835,506 | $45,126,000 | 2.76% |
| WASATCH ADVISORS LP | 2,844,908 | $153,653,000 | 2.29% |
| Opus Point Partners Management, LLC | 67,953 | $3,670,000 | 2.06% |
| CORRADO ADVISORS, LLC | 43,050 | $2,325,000 | 1.48% |
| Baillie Gifford | 16,795,793 | $907,142,000 | 1.42% |